Home LiteratureArticle Details
PMID: 21980303 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Twin Study

Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis.

PLoS genetics ·Vol. 7 ·No. 9 ·2011-09-00 ·Pages e1002300

Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, Dias KR, Bell CG, Tost J, Boehm BO, Beck S, Leslie RD

Abstract

Monozygotic (MZ) twin pair discordance for childhood-onset Type 1 Diabetes (T1D) is ∼50%, implicating roles for genetic and non-genetic factors in the aetiology of this complex autoimmune disease. Although significant progress has been made in elucidating the genetics of T1D in recent years, the non-genetic component has remained poorly defined. We hypothesized that epigenetic variation could underlie some of the non-genetic component of T1D aetiology and, thus, performed an epigenome-wide association study (EWAS) for this disease. We generated genome-wide DNA methylation profiles of purified CD14+ monocytes (an immune effector cell type relevant to T1D pathogenesis) from 15 T1D-discordant MZ twin pairs. This identified 132 different CpG sites at which the direction of the intra-MZ pair DNA methylation difference significantly correlated with the diabetic state, i.e. T1D-associated methylation variable positions (T1D-MVPs). We confirmed these T1D-MVPs display statistically significant intra-MZ pair DNA methylation differences in the expected direction in an independent set of T1D-discordant MZ pairs (P = 0.035). Then, to establish the temporal origins of the T1D-MVPs, we generated two further genome-wide datasets and established that, when compared with controls, T1D-MVPs are enriched in singletons both before (P = 0.001) and at (P = 0.015) disease diagnosis, and also in singletons positive for diabetes-associated autoantibodies but disease-free even after 12 years follow-up (P = 0.0023). Combined, these results suggest that T1D-MVPs arise very early in the etiological process that leads to overt T1D. Our EWAS of T1D represents an important contribution toward understanding the etiological role of epigenetic variation in type 1 diabetes, and it is also the first systematic analysis of the temporal origins of disease-associated epigenetic variation for any human complex disease.

MeSH Terms
Adolescent Adult Child Child, Preschool CpG Islands/genetics DNA Methylation/genetics Diabetes Mellitus, Type 1/diagnosis,genetics Epigenesis, Genetic/genetics Epigenomics Female Follow-Up Studies Genetic Variation Genome-Wide Association Study Humans Lipopolysaccharide Receptors/genetics Male Middle Aged Monocytes/cytology,metabolism Twins, Monozygotic
Chemicals
Lipopolysaccharide Receptors
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Rakyan Vardhman K
Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. v.rakyan@qmul.ac.uk
Beyan Huriya
Down Thomas A
Hawa Mohammed I
Maslau Siarhei
Aden Deeqo
Daunay Antoine
Busato Florence
Mein Charles A
Manfras Burkhard
Dias Kerith-Rae M
Bell Christopher G
Tost Jörg
Boehm Bernhard O
Beck Stephan
Leslie R David
Conflict of Interest

The authors have declared that no competing interests exist.

References (35)
35 references, click to expand
  1. Prediction and interaction in complex disease genetics: experience in type 1 diabetes.
    PLoS Genet. 2009 Jul;5(7):e1000540 PMID: 19584936
  2. Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes.
    Diabetes. 2006 Dec;55(12):3439-45 PMID: 17130490
  3. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes.
    J Exp Med. 2008 Dec 22;205(13):2975-84 PMID: 19075291
  4. Metastable epialleles in mammals.
    Trends Genet. 2002 Jul;18(7):348-51 PMID: 12127774
  5. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.
    J Clin Invest. 1999 Aug;104(4):515-23 PMID: 10449443
  6. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.
    Nat Genet. 2003 Mar;33 Suppl:245-54 PMID: 12610534
  7. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus.
    Genome Res. 2010 Feb;20(2):170-9 PMID: 20028698
  8. Finding the missing heritability of complex diseases.
    Nature. 2009 Oct 8;461(7265):747-53 PMID: 19812666
  9. DNA methylation profiling of human chromosomes 6, 20 and 22.
    Nat Genet. 2006 Dec;38(12):1378-85 PMID: 17072317
  10. Personalized epigenomic signatures that are stable over time and covary with body mass index.
    Sci Transl Med. 2010 Sep 15;2(49):49ra67 PMID: 20844285
  11. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus.
    BMC Med Genomics. 2010 Aug 05;3:33 PMID: 20687937
  12. Inherited epigenetic variation--revisiting soft inheritance.
    Nat Rev Genet. 2006 May;7(5):395-401 PMID: 16534512
  13. Genome-wide DNA methylation profiling using Infinium® assay.
    Epigenomics. 2009 Oct;1(1):177-200 PMID: 22122642
  14. Dietary intervention in infancy and later signs of beta-cell autoimmunity.
    N Engl J Med. 2010 Nov 11;363(20):1900-8 PMID: 21067382
  15. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States.
    Diabetologia. 2001 Mar;44(3):354-62 PMID: 11317668
  16. Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease.
    Proc Natl Acad Sci U S A. 2010 Jan 26;107 Suppl 1:1757-64 PMID: 20080672
  17. Environmental triggers and determinants of type 1 diabetes.
    Diabetes. 2005 Dec;54 Suppl 2:S125-36 PMID: 16306330
  18. Etiology of type 1 diabetes.
    Immunity. 2010 Apr 23;32(4):457-67 PMID: 20412756
  19. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain.
    FASEB J. 2010 Aug;24(8):3036-51 PMID: 20375269
  20. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes.
    Diabetologia. 2007 Mar;50(3):596-601 PMID: 17221211
  21. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
    N Engl J Med. 2008 Oct 30;359(18):1909-20 PMID: 18843118
  22. Epigenome-wide association studies for common human diseases.
    Nat Rev Genet. 2011 Jul 12;12(8):529-41 PMID: 21747404
  23. Epigenetic differences arise during the lifetime of monozygotic twins.
    Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10604-9 PMID: 16009939
  24. DNA methylation profiles in monozygotic and dizygotic twins.
    Nat Genet. 2009 Feb;41(2):240-5 PMID: 19151718
  25. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
    Nature. 2007 Jun 7;447(7145):661-78 PMID: 17554300
  26. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
    Diabetes Care. 1999 Dec;22(12):2049-54 PMID: 10587841
  27. The effect of infections on susceptibility to autoimmune and allergic diseases.
    N Engl J Med. 2002 Sep 19;347(12):911-20 PMID: 12239261
  28. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study.
    Diabetes. 2003 Apr;52(4):1052-5 PMID: 12663480
  29. Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.
    J Mol Diagn. 2007 Sep;9(4):510-20 PMID: 17690210
  30. Epidemiology and immunogenetic background of islet cell antibody--positive nondiabetic schoolchildren. Ulm-Frankfurt population study.
    Diabetes. 1991 Nov;40(11):1435-9 PMID: 1936604
  31. Genetics, pathogenesis and clinical interventions in type 1 diabetes.
    Nature. 2010 Apr 29;464(7293):1293-300 PMID: 20432533
  32. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus.
    PLoS One. 2010 Nov 18;5(11):e14040 PMID: 21124985
  33. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
    Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5 PMID: 17942684
  34. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
    Diabetes. 1997 Aug;46(8):1270-5 PMID: 9231650
  35. Age-dependent influences on the origins of autoimmune diabetes: evidence and implications.
    Diabetes. 2004 Dec;53(12):3033-40 PMID: 15561931
Article Info
Journal
PLoS genetics
Abbr.
PLoS Genet
ISSN
1553-7404
Published
2011-09-00
Epub
2011-00-29
Pages
e1002300
Language
English
Region
United States
NLM ID
101239074
PMCID
PMC3183089
Subset
IM
Grants
Wellcome Trust · 079895 · United Kingdom
Wellcome Trust · 084071 · United Kingdom
Department of Health · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com